Pasar al contenido principal

Innovation Workshop Series – How to discover new medicines: From target to drug candidates

11 Dic 18

How to discover new medicines: From target to drug candidates by Israel Ramos, Technology Transfer Consultant at IRB Barcelona





How to discover new medicines? Our speaker, Israel Ramos, will give a practical overview about how the pharmaceutical industry designs and runs early drug discovery programs. Drug discovery programs start from target discovery until the selection of a drug candidate—a small molecule ready to enter pre-clinical phases.

He will also provide practical tips on how to design and perform a screening cascade for your targets, taking into account features such as compound efficacy, safety, absorption, metabolism, among others.

Key points addressed during the talk:

  • Drug discovery and screening design.
  • Screening cascade and Critical Path.
  • Go / No go decisions.
  • Practical tips and key words in industry to apply to your project.

If you want to find out how to run a screening assay for your target and design critical paths to advance your compounds, this workshop is for you!

Organizer: IRB Innovation Department
Date: Tuesday, December 11, 10:00-11:00
Place: Aula Fèlix Serratosa, Parc Científic de Barcelona, Spain
Language: English


The workshop is offered to the entire IRB Barcelona community and IRB Barcelona alumni (40 places are available).

If you would like to attend this presentation, please register in the following link before 4 December 2018. A confirmation email will be sent after the registration deadline.






Israel Ramos, former Head of Screening at Almirall, has been involved in 20 drug discovery campaigns, as well as forming part of the Research Committee and Programme Generation Team.

Israel has extensive experience in in vitro assay development, High-Throughput Screening and compound characterization assays (allosterism, compound residence time, etc.) for a range of protein targets (enzymes, GPCRs, ion channels, nuclear receptors, protein-protein interactions, etc.).